BioSpace News Archive

Akari Therapeutics, Plc (Nasdaq: AKTX), a biopharmaceutical company focused on innovative therapeutics to treat autoimmune and inflammatory diseases where the complement and/or leukotriene systems are implicated, announces new preclinical data indicating that nomacopan significantly reduced both retinal inflammation and intraocular VEGF.

Kerrisdale Capital, a private investment manager, has published a report explaining its short position in Principia Biopharma Inc. (NASDAQ: PRNB), a biopharmaceutical company whose $2 billion valuation is driven by misleading clinical data and an ineffective strategy of treating autoimmune diseases with BTK inhibitors

Medical Group Management Association (MGMA) and Jackson Physician Search, a firm specializing in the permanent recruitment of physicians, physician leaders and advanced practice providers throughout the U.S., today announced a new executive partnership designed to help medical practices operate more efficiently, while providing optimal levels of care.

Zymeworks Inc., a clinical stage biopharmaceutical company developing multifunctional biotherapeutics, announced the closing of its previously announced underwritten public offering.

IBEX Technologies Inc. announces that on January 23, 2020, its Board of Directors granted 455,000 stock options to Board Members and staff to replace options that expired on December 19, 2019.

This new standard in bioelectronic medicine research demonstrates the potential impact of long-term vagus nerve stimulation to treat a wide range of diseases and conditions

Profound Medical Corp. (TSX:PRN; NASDAQ: PROF) (“Profound” or the “Company”) is pleased to announce that it has closed its previously-announced underwritten offering (the “Offering”) of common shares of the Company (the “Common Shares”) at a price of US$11.65 per Common Share.

uLab Systems, the creator of the state-of-the-art aligner planning software, has completed an $18M Series D financing round led by Park West Asset Management and supported by minority investors including Ortho Studio Express.

Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced that it has been approved by retail giant, Walmart Inc. (“Walmart”), to operate a Retail Link account (“Retail Link”).

StemoniX, a biotech company revolutionizing how new medicines are discovered, announced today that its Director of Applications, Oivin Guichert, Ph.D., will deliver a podium presentation highlighting the company’s microBrain technology at the SLAS (Society for Laboratory Automation and Screening) 2020 International Conference & Exhibition at the San Diego Convention Center, Jan. 27-29, 2020.